Xin He
Direktor/Vorstandsmitglied bei BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION
Profil
Xin He is the founder of RHEI Pharmaceuticals, Inc. He is currently serving as the Director at Elpiscience Biopharma Ltd.
Additionally, he holds the position of Independent Non-Executive Director at Biosino Bio-Technology & Science, Inc. since 2024.
Dr. He is also a Non-Executive Director at Elpiscience Biopharmaceuticals, Inc. since 2019.
He obtained a doctorate degree from Yale University and a graduate degree from Princeton University.
Aktive Positionen von Xin He
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Direktor/Vorstandsmitglied | 28.06.2024 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - |
Elpiscience Biopharmaceuticals, Inc.
 Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 28.12.2019 |
Ehemalige bekannte Positionen von Xin He
| Unternehmen | Position | Ende |
|---|---|---|
RHEI Pharmaceuticals, Inc.
 RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Vorstandsvorsitzender | - |
Ausbildung von Xin He
| Yale University | Doctorate Degree |
| Princeton University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
